Collegeville, PA, United States of America

Mark Andrew Seefeld

USPTO Granted Patents = 37 

 

Average Co-Inventor Count = 3.3

ph-index = 13

Forward Citations = 391(Granted Patents)


Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
37 patents (USPTO):

Title: Mark Andrew Seefeld: Innovator in Pharmaceutical Sciences

Introduction

Mark Andrew Seefeld is a prominent inventor based in Collegeville, Pennsylvania, known for his significant contributions in the field of pharmaceutical sciences. With an impressive portfolio of 37 patents, Seefeld has developed groundbreaking inventions that aim to address a variety of health challenges, particularly those related to aging and chronic diseases.

Latest Patents

Among his latest patents, Seefeld has made noteworthy advancements with his invention titled "Substituted Bridged Urea Analogs as Sirtuin Modulators." This invention introduces novel substituted bridged urea analog compounds, which are potentially useful as Sirtuin Modulators. These compounds are designed to increase the lifespan of cells and are aimed at treating or preventing various diseases, including but not limited to aging-related disorders, diabetes, obesity, neurodegenerative diseases, and cancer. Another significant patent involves "Inhibitors of AkT Activity." This invention encompasses novel heterocyclic carboxamide compounds that serve as inhibitors of protein kinase B activity, thus contributing to the treatment of cancer and arthritis.

Career Highlights

Seefeld's career is marked by his work with leading pharmaceutical companies such as Affinium Pharmaceuticals, Inc. and Glaxo Group Limited. His expertise and innovative spirit have made him a valuable asset in the development of new therapeutic agents, reflecting a sustained commitment to advancing healthcare through scientific discovery.

Collaborations

Throughout his career, Seefeld has collaborated with notable professionals like William Henry Miller and Kenneth Allen Newlander. These partnerships have fostered a collaborative environment that enhances the quality and impact of the innovations they pursue together.

Conclusion

Mark Andrew Seefeld stands out as a distinguished inventor whose innovations have the potential to significantly impact the pharmaceutical landscape. Through his extensive patent portfolio and collaborative efforts, he continues to contribute to advancements in medical science, paving the way for new treatment options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…